Jazz Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	10,528	7,445	7,744	10,031	7,831	9,196
Market Cap Growth	43.29%	-3.86%	-22.80%	28.09%	-14.84%	8.89%
Enterprise Value	13,910	11,032	11,945	14,946	13,570	9,525
Last Close Price	173.25	123.15	123.00	159.31	127.40	165.05
PE Ratio	-	13.29	18.67	-	-	38.54
Forward PE	8.06	5.72	6.29	8.54	8.23	10.20
PS Ratio	2.53	1.83	2.02	2.74	2.53	3.89
PB Ratio	2.66	1.82	2.07	3.25	1.98	2.51
P/TBV Ratio	-	-	-	-	-	18.16
P/FCF Ratio	7.88	5.48	7.25	8.07	10.43	10.40
P/OCF Ratio	7.56	5.33	7.09	7.89	10.06	10.22
PEG Ratio	0.69	0.37	0.50	1.14	0.62	2.62
EV/Sales Ratio	3.35	2.71	3.12	4.08	4.39	4.03
EV/EBITDA Ratio	8.65	7.25	8.24	10.18	13.20	9.13
EV/EBIT Ratio	15.08	12.80	14.73	17.81	28.55	12.44
EV/FCF Ratio	10.41	8.13	11.18	12.03	18.07	10.77
Debt / Equity Ratio	1.37	1.51	1.55	1.89	1.56	0.62
Debt / EBITDA Ratio	3.31	3.97	3.93	3.90	5.84	2.11
Debt / FCF Ratio	4.06	4.54	5.43	4.68	8.22	2.55
Net Debt / Equity Ratio	0.85	0.78	1.12	1.60	1.41	0.03
Net Debt / EBITDA Ratio	2.10	2.09	2.88	3.36	5.43	0.11
Net Debt / FCF Ratio	2.53	2.34	3.90	3.97	7.44	0.14
Asset Turnover	0.35	0.35	0.35	0.32	0.33	0.39
Inventory Turnover	0.65	0.58	0.43	0.30	0.37	1.71
Quick Ratio	1.24	3.57	1.52	1.64	1.43	3.87
Current Ratio	1.65	4.46	2.24	2.79	3.23	4.34
Return on Equity (ROE)	-9.06%	14.31%	12.16%	-6.35%	-8.65%	7.05%
Return on Assets (ROA)	4.88%	4.60%	4.56%	4.53%	3.15%	7.92%
Return on Invested Capital (ROIC)	12.46%	11.36%	10.18%	9.55%	7.13%	17.70%
Return on Capital Employed (ROCE)	10.20%	7.90%	8.20%	8.50%	4.10%	13.00%
Earnings Yield	-3.50%	7.52%	5.36%	-2.23%	-4.21%	2.60%
FCF Yield	12.70%	18.24%	13.79%	12.39%	9.59%	9.62%
Buyback Yield / Dilution	10.58%	8.41%	-15.23%	-4.77%	-5.62%	1.80%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q